These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10504005)

  • 1. Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Lorenzi C; Gasperini M; Smeraldi E
    J Psychiatr Res; 1999; 33(5):371-7. PubMed ID: 10504005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders.
    Serretti A; Lorenzi C; Lilli R; Smeraldi E
    J Psychiatr Res; 2000; 34(2):89-98. PubMed ID: 10758249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melancholic features and response to lithium prophylaxis in mood disorders.
    Serretti A; Lattuada E; Franchini L; Smeraldi E
    Depress Anxiety; 2000; 11(2):73-9. PubMed ID: 10812532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders.
    Cusin C; Serretti A; Lattuada E; Lilli R; Lorenzi C; Mandelli L; Pisati E; Smeraldi E
    J Psychiatr Res; 2001; 35(4):217-23. PubMed ID: 11578639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan hydroxylase gene and major psychoses.
    Serretti A; Lilli R; Lorenzi C; Lattuada E; Cusin C; Smeraldi E
    Psychiatry Res; 2001 Aug; 103(1):79-86. PubMed ID: 11472792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Lorenzi C; Franchini L; Smeraldi E
    Int J Neuropsychopharmacol; 1998 Dec; 1(2):125-129. PubMed ID: 11281956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
    Sugawara H; Sakamoto K; Harada T; Ishigooka J
    J Affect Disord; 2010 Sep; 125(1-3):165-8. PubMed ID: 20089312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Lorenzi C; Franchini L; Di Bella D; Catalano M; Smeraldi E
    Psychiatry Res; 1999 Jul; 87(1):7-19. PubMed ID: 10512150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How effective is lithium in the prevention of relapse in bipolar disorder? A prospective naturalistic follow-up study.
    Silverstone T; McPherson H; Hunt N; Romans S
    Aust N Z J Psychiatry; 1998 Feb; 32(1):61-6. PubMed ID: 9565184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium and recurrence in a long-term follow-up of bipolar affective disorder.
    Coryell W; Winokur G; Solomon D; Shea T; Leon A; Keller M
    Psychol Med; 1997 Mar; 27(2):281-9. PubMed ID: 9089821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
    Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Mandelli L; Lorenzi C; Smeraldi E
    Pharmacogenomics J; 2001; 1(1):71-7. PubMed ID: 11913731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients.
    Licht RW; Vestergaard P; Rasmussen NA; Jepsen K; Brodersen A; Hansen PE
    Acta Psychiatr Scand; 2001 Nov; 104(5):387-90. PubMed ID: 11722321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.
    Michelon L; Meira-Lima I; Cordeiro Q; Miguita K; Breen G; Collier D; Vallada H
    Neurosci Lett; 2006 Aug; 403(3):288-93. PubMed ID: 16787706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization.
    Müller-Oerlinghausen B
    Compr Psychiatry; 2000; 41(2 Suppl 1):26-31. PubMed ID: 10746901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do patients in a lithium outpatient clinic know about lithium therapy?
    Schaub RT; Berghoefer A; Müller-Oerlinghausen B
    J Psychiatry Neurosci; 2001 Sep; 26(4):319-24. PubMed ID: 11590971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is lithium still worth using? An update of selected recent research.
    Baldessarini RJ; Tondo L; Hennen J; Viguera AC
    Harv Rev Psychiatry; 2002; 10(2):59-75. PubMed ID: 11897747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.